Ellie is a UK and European qualified patent attorney with a strong academic background in Life Sciences, particularly in Plant Sciences. In addition, Ellie holds a qualification as a Patent Attorney Litigator with advocacy experience working on oppositions and appeals before the European Patent Office. She specialises in dealing with technology in the Gene Editing, Antibody, Peptide, AgBio, and Microbiology fields. Ellie is interested in helping SMEs, start-ups and spin-outs maximise their potential by exploiting IP protection and good IP management. She enjoys working with challenging IP portfolios and developing IP strategies. In particular for those cases experiencing difficulty in European prosecution.
Ellie has worked with all types of clients, from multinational companies including AstraZeneca, Novartis, and Dow AgroSciences, to small start ups and spin outs such as Pepgen and Tissue Regenix.
(Cantab) Natural Sciences - Double First Class Honours
Intellectual Property Litigation and Advocacy Certificate - Nottingham Trent University - Distinction
Awarded to undergraduates who achieved a first class in university examinations, achieved in 2009 and 2010
Awarded to undergraduate who achieved highest overall marks in Plant Sciences, awarded in 2009 and 2010
Awarded by CIPA to the patent trainee who achieved the highest mark in the P7 examination (UK trademark law)
September 22nd 2022
July 2nd 2021
January 7th 2021
November 4th 2020
Ellie regularly holds tutorials for trainees within HGF, and has acted as an ongoing mentor for those trainees taking UK finals examinations.
She has also recently acted as a CIPA designated mentor for candidates re-taking the UK law exam (FD1).
In the past, Ellie held the position of the Northern Informals Secretary for several years organising social and educational events for trainees across the North of England, including organising and implementing a series of tutorials with tutors from different firms.
A patent is a legal right that enables the patent holder to prevent others from making and using their invention in the country where the patent is granted. To many …Read article
Order of the classifications listed on the front of a patent and why it matters? On 1 June 2023, ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE lodged a statement of revocation of …Read article
HGF is pleased to invite you to our upcoming German-language webinar in cooperation with the BVIZ on “In- and Out-licensing of Technologies” on 16th of November 2023. The webinar will …Event details
The advent of commercial launch capabilities has opened up space as a unique frontier for innovation. However, in space, any acts of patent infringement almost always go unseen. Thus, it’s …Read article
Any communications sent from the EPO on or after 1 November 2023 will no longer have the “ten day rule” applied to them. This means that communications are deemed to …Read article
HGF is pleased to invite you to our upcoming German-language seminar on “In- and Out-licensing of Technologies” in Salzburg and Dresden. The seminar will offer you the opportunity to gain …Event details
Bioforward, OBN’s ‘Roadmap for Growth’ Life Sciences event is set to take place at The King’s Centre in Oxford on Tuesday 26th September 2023. This event is designed to provide the support, skills, know-how …Event details
The integration of artificial intelligence (AI) into healthcare has ushered in a new era of personalised medicine, promising more effective and tailored treatments for patients. Traditional medical approaches often adopt …Read article
If you would like to discuss how HGF could help you, contact one of our IP specialists.